Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Vallera

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Toxins|May 31, 2016
CD133, Selectively Targeting the Root of CancerJörg U Schmohl, Daniel A Vallera
Biomedicines|December 23, 2018
Immunotoxins Targeting B cell Malignancy-Progress and Problems With ImmunogenicityDaniel A Vallera, Robert J Kreitman
Neurosurgical Focus|May 20, 2006
Efficacy of antiangiogenic targeted toxins against glioblastoma multiformeWalter A Hall, Daniel A Vallera
Oral Oncology|July 24, 2012
Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinomaNate N Waldron, Seunguk Oh, Daniel A Vallera
Molecular Cancer Therapeutics|December 22, 2022
Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled NanoringsJacob Petersburg, Daniel A Vallera, Carston R Wagner
Journal of Neuro-Oncology|December 18, 2007
Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft modelBrad J Stish, Seunguk Oh, Daniel A Vallera
Journal of the American Chemical Society|August 1, 2015
Prosthetic Antigen ReceptorsJingjing Shen, Daniel A Vallera, Carston R Wagner
Journal of Neuro-Oncology|May 23, 2013
Diphtheria toxin-based targeted toxin therapy for brain tumorsYan Michael Li, Daniel A Vallera, Walter A Hall
Toxins|October 17, 2015
Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug DevelopmentJoerg U Schmohl, Deborah Todhunter, Seung Oh, et al.
Biomolecules|July 8, 2020
Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid TumorsFelix Oh, Jaime F Modiano, Veronika Bachanova, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Toxins|May 31, 2016
CD133, Selectively Targeting the Root of CancerJörg U Schmohl, Daniel A Vallera
Biomedicines|December 23, 2018
Immunotoxins Targeting B cell Malignancy-Progress and Problems With ImmunogenicityDaniel A Vallera, Robert J Kreitman
Neurosurgical Focus|May 20, 2006
Efficacy of antiangiogenic targeted toxins against glioblastoma multiformeWalter A Hall, Daniel A Vallera
Oral Oncology|July 24, 2012
Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinomaNate N Waldron, Seunguk Oh, Daniel A Vallera
Molecular Cancer Therapeutics|December 22, 2022
Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled NanoringsJacob Petersburg, Daniel A Vallera, Carston R Wagner
Journal of Neuro-Oncology|December 18, 2007
Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft modelBrad J Stish, Seunguk Oh, Daniel A Vallera
Journal of the American Chemical Society|August 1, 2015
Prosthetic Antigen ReceptorsJingjing Shen, Daniel A Vallera, Carston R Wagner
Journal of Neuro-Oncology|May 23, 2013
Diphtheria toxin-based targeted toxin therapy for brain tumorsYan Michael Li, Daniel A Vallera, Walter A Hall
Toxins|October 17, 2015
Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug DevelopmentJoerg U Schmohl, Deborah Todhunter, Seung Oh, et al.
Biomolecules|July 8, 2020
Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid TumorsFelix Oh, Jaime F Modiano, Veronika Bachanova, et al.
Pageof 9